Skip to main content

Table 1 General characteristics of the final analysis data after the removal of an outlier sample

From: The progression rate of spinocerebellar ataxia type 3 varies with disease stage

 

Patients

Total subjects, No

81

Gender (female), No. (%)

43(53.09%)

Mean number of examinations per participant, Mean ± SD [Range]

7.830 ± 3.670 [1–16]

Mean number of years of follow up per participant, Mean ± SD [Range]

8.280 ± 4.190 [0–15.300]

Mean interval between visits per participant (years), Mean ± SD [Range]

1.210 ± 0.783 [0.071–7.010]

ATXN3 CAGexp, Mean ± SD [Range]

67.700 ± 3.650 [60.000–75.000]

AOga (years), Mean ± SD [Range]

42.100 ± 9.880 [20.000–72.000]

Disease duration at first examination (years), Mean ± SD [Range]

7.110 ± 5.030 [0.529–24.500]

Age at first examination (years), Mean ± SD [Range]

49.200 ± 11.300 [22.200–77.000]

ICARS score at first examination, Mean ± SD [Range]

21.600 ± 15.500 [2.000–81.000]

  1. No. = Number; SD = standard deviation; ATXN3 CAGexp = the length of expanded ATXN3 allele; AOga = Age at onset of gait ataxia